FAS and myeloid sarcoma: A protective effect of NK cells could also be demonstrated in patients with multiple sclerosis (MS) (93, 94), high surface expression levels of CD95 (Fas) being detected on NK cells derived from patients in disease remission which were classified as “NK2” cells.